These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours. Rafii A; Mirshahi P; Poupot M; Faussat AM; Simon A; Ducros E; Mery E; Couderc B; Lis R; Capdet J; Bergalet J; Querleu D; Dagonnet F; Fournié JJ; Marie JP; Pujade-Lauraine E; Favre G; Soria J; Mirshahi M PLoS One; 2008; 3(12):e3894. PubMed ID: 19079610 [TBL] [Abstract][Full Text] [Related]
24. Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers. Klukovits A; Schally AV; Szalontay L; Vidaurre I; Papadia A; Zarandi M; Varga JL; Block NL; Halmos G Cancer; 2012 Feb; 118(3):670-80. PubMed ID: 21751186 [TBL] [Abstract][Full Text] [Related]
25. Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer. Greenaway J; Moorehead R; Shaw P; Petrik J Gynecol Oncol; 2008 Feb; 108(2):385-94. PubMed ID: 18036641 [TBL] [Abstract][Full Text] [Related]
26. Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer. Hasumi Y; Mizukami H; Urabe M; Kohno T; Takeuchi K; Kume A; Momoeda M; Yoshikawa H; Tsuruo T; Shibuya M; Taketani Y; Ozawa K Cancer Res; 2002 Apr; 62(7):2019-23. PubMed ID: 11929819 [TBL] [Abstract][Full Text] [Related]
27. [Relation between the expression of hypoxia inducible factor-1alpha and angiogenesis in ovarian cancer using tissue microarray]. Luo J; Peng ZL; Yang KX; Wang H; Yang H; Dong DD; Yao XY Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):38-41. PubMed ID: 15774091 [TBL] [Abstract][Full Text] [Related]
28. Adipose-derived mesenchymal stem cells promote cell proliferation and invasion of epithelial ovarian cancer. Chu Y; Tang H; Guo Y; Guo J; Huang B; Fang F; Cai J; Wang Z Exp Cell Res; 2015 Sep; 337(1):16-27. PubMed ID: 26209607 [TBL] [Abstract][Full Text] [Related]
29. Squalamine and cisplatin block angiogenesis and growth of human ovarian cancer cells with or without HER-2 gene overexpression. Li D; Williams JI; Pietras RJ Oncogene; 2002 Apr; 21(18):2805-14. PubMed ID: 11973639 [TBL] [Abstract][Full Text] [Related]
30. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis. Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336 [TBL] [Abstract][Full Text] [Related]
31. Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice. Hamilton TC; Young RC; Louie KG; Behrens BC; McKoy WM; Grotzinger KR; Ozols RF Cancer Res; 1984 Nov; 44(11):5286-90. PubMed ID: 6333272 [TBL] [Abstract][Full Text] [Related]
32. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Deryugina EI; Soroceanu L; Strongin AY Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713 [TBL] [Abstract][Full Text] [Related]
33. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation. Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721 [TBL] [Abstract][Full Text] [Related]
34. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966 [TBL] [Abstract][Full Text] [Related]
35. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948 [TBL] [Abstract][Full Text] [Related]
36. Phenotypic variations and differential migration of NIH:OVCAR-3 ovarian carcinoma cells isolated from athymic mice. Veatch AL; Carson LF; Ramakrishnan S Clin Exp Metastasis; 1995 May; 13(3):165-72. PubMed ID: 7750204 [TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model. Hu L; Hofmann J; Holash J; Yancopoulos GD; Sood AK; Jaffe RB Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6966-71. PubMed ID: 16203789 [TBL] [Abstract][Full Text] [Related]
39. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth. Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331 [TBL] [Abstract][Full Text] [Related]
40. Functional and molecular mapping of uncoupling between vascular permeability and loss of vascular maturation in ovarian carcinoma xenografts: the role of stroma cells in tumor angiogenesis. Gilad AA; Israely T; Dafni H; Meir G; Cohen B; Neeman M Int J Cancer; 2005 Nov; 117(2):202-11. PubMed ID: 15880497 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]